Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if the type of Fc gamma RIIIa receptor that a
particular patient's immune cells possess influences how they respond to rituximab and other
monoclonal antibodies.